Veterinary Medicines

PYROCAM 20 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES

Authorised
  • Meloxicam
Download as PDF

Product identification

Medicine name:
PYROCAM 20 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES
Pyrocam, 20 mg/ml süstelahus veistele, sigadele ja hobustele
Active substance:
  • Meloxicam
Target species:
  • Pig
  • Cattle
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Meloxicam
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        5
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        15
        day
      • Milk
        5
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        15
        day
      • Milk
        5
        day
    • Horse
      • Meat and offal
        5
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AC06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Available in:
  • Estonia
Package description:
  • Cardboard box with 1 colourless glass injection vial type I containing 20 ml and closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
  • Cardboard box with 1 colourless glass injection vial type I containing 50 ml and closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
  • Cardboard box with 1 colourless glass injection vial type I containing 100 ml and closed with a bromobutyl rubber stopper and sealed with an aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1160024
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0471/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 8/07/2024
Download